Metformin action over gut microbiota is related to weight and glycemic control in gestational diabetes mellitus: A randomized trial
Background: Metformin, which is known to produce profound changes in gut microbiota, is being increasingly used in gestational diabetes mellitus (GDM). The aim of this study was to elucidate the differences in gut microbiota composition and function in women with GDM treated with metformin compared...
Guardado en:
Autores principales: | María Molina-Vega, María J. Picón-César, Carolina Gutiérrez-Repiso, Andrea Fernández-Valero, Fuensanta Lima-Rubio, Stella González-Romero, Isabel Moreno-Indias, Francisco J. Tinahones |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ff6ab387edbf4bb9adea2651aba7194f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Difference in Gut Microbiota between the First and the Second Trimester of Pregnancy and the Association of Gut Microbiota with Gestational Diabetes Mellitus: A Prospective Cohort Study
por: WANG Pei, et al.
Publicado: (2021) -
Gut microbiota of patients with type 2 diabetes and gastrointestinal intolerance to metformin differs in composition and functionality from tolerant patients
por: Cristina Ma Díaz-Perdigones, et al.
Publicado: (2022) -
Risk Factors Screening for Gestational Diabetes Mellitus Heterogeneity in Chinese Pregnant Women: A Case–Control Study
por: Wang N, et al.
Publicado: (2021) -
Effects of Metformin on the Gut Microbiota in Obesity and Type 2 Diabetes Mellitus
por: Zhang Q, et al.
Publicado: (2020) -
PEARLS randomized lifestyle trial in pregnant Hispanic women with overweight/obesity: gestational weight gain and offspring birthweight
por: Trak-Fellermeier MA, et al.
Publicado: (2019)